These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 10999838)

  • 1. High-dose growth hormone does not affect proinflammatory cytokine (tumor necrosis factor-alpha, interleukin-6, and interferon-gamma) release from activated peripheral blood mononuclear cells or after minimal to moderate surgical stress.
    Zarkesh-Esfahani SH; Kolstad O; Metcalfe RA; Watson PF; von Laue S; Walters S; Revhaug A; Weetman AP; Ross RJ
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3383-90. PubMed ID: 10999838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone enhances proinflammatory cytokine production by monocytes in whole blood.
    Uronen-Hansson H; Allen ML; Lichtarowicz-Krynska E; Aynsley-Green A; Cole TJ; Höidén-Guthenberg I; Fryklund L; Klein N
    Growth Horm IGF Res; 2003 Oct; 13(5):282-6. PubMed ID: 12932750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of growth hormone therapy on the proinflammatory cytokine profile in growth hormone-deficient children.
    Pagani S; Meazza C; Travaglino P; Moretta A; Bozzola M
    Eur Cytokine Netw; 2005; 16(1):65-9. PubMed ID: 15809208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose leptin activates human leukocytes via receptor expression on monocytes.
    Zarkesh-Esfahani H; Pockley G; Metcalfe RA; Bidlingmaier M; Wu Z; Ajami A; Weetman AP; Strasburger CJ; Ross RJ
    J Immunol; 2001 Oct; 167(8):4593-9. PubMed ID: 11591788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1, -6 and tumor necrosis factor-alpha release is down-regulated in whole blood from septic patients.
    Kremer JP; Jarrar D; Steckholzer U; Ertel W
    Acta Haematol; 1996; 95(3-4):268-73. PubMed ID: 8677754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT5 activation by human GH protects insulin-producing cells against interleukin-1beta, interferon-gamma and tumour necrosis factor-alpha-induced apoptosis independent of nitric oxide production.
    Jensen J; Galsgaard ED; Karlsen AE; Lee YC; Nielsen JH
    J Endocrinol; 2005 Oct; 187(1):25-36. PubMed ID: 16214938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of CO2 on cytokine concentrations in endotoxin-stimulated human whole blood.
    Kimura D; Totapally BR; Raszynski A; Ramachandran C; Torbati D
    Crit Care Med; 2008 Oct; 36(10):2823-7. PubMed ID: 18766096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding.
    Chen Y; Sun D; Krishnamurthy VM; Rabkin R
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1856-62. PubMed ID: 17327369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in cytokine production and surface antigen expression of peripheral blood mononuclear cells after surgery.
    Ono S; Tsujimoto H; Hiraki S; Takahata R; Kinoshita M; Mochizuki H
    Am J Surg; 2005 Sep; 190(3):439-44. PubMed ID: 16105533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
    Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
    Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture.
    Thissen JP; Verniers J
    Endocrinology; 1997 Mar; 138(3):1078-84. PubMed ID: 9048612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A regulatory role of prolactin, growth hormone, and corticosteroids for human T-cell production of cytokines.
    Dimitrov S; Lange T; Fehm HL; Born J
    Brain Behav Immun; 2004 Jul; 18(4):368-74. PubMed ID: 15157954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of radioactive iodine therapy on cytokine production in Graves' disease: transient increases in interleukin-4 (IL-4), IL-6, IL-10, and tumor necrosis factor-alpha, with longer term increases in interferon-gamma production.
    Jones BM; Kwok CC; Kung AW
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4106-10. PubMed ID: 10566657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine production by human peripheral blood mononuclear cells: differential senstivity to glutamine availability.
    Yaqoob P; Calder PC
    Cytokine; 1998 Oct; 10(10):790-4. PubMed ID: 9811533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma.
    Galve-de Rochemonteix B; Nicod LP; Dayer JM
    Am J Respir Cell Mol Biol; 1996 Mar; 14(3):279-87. PubMed ID: 8845179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of growth hormone action in models of inflammation.
    Bergad PL; Schwarzenberg SJ; Humbert JT; Morrison M; Amarasinghe S; Towle HC; Berry SA
    Am J Physiol Cell Physiol; 2000 Dec; 279(6):C1906-17. PubMed ID: 11078706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients.
    Parihar R; Nadella P; Lewis A; Jensen R; De Hoff C; Dierksheide JE; VanBuskirk AM; Magro CM; Young DC; Shapiro CL; Carson WE
    Clin Cancer Res; 2004 Aug; 10(15):5027-37. PubMed ID: 15297404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric analysis of cytokine production by normal human peripheral blood dendritic cells and monocytes: comparative analysis of different stimuli, secretion-blocking agents and incubation periods.
    Bueno C; Almeida J; Alguero MC; Sánchez ML; Vaquero JM; Laso FJ; San Miguel JF; Escribano L; Orfao A
    Cytometry; 2001 Feb; 46(1):33-40. PubMed ID: 11241505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone secretion and immunological function of a male patient with a homozygous STAT5b mutation.
    Walenkamp MJ; Vidarsdottir S; Pereira AM; Karperien M; van Doorn J; van Duyvenvoorde HA; Breuning MH; Roelfsema F; Kruithof MF; van Dissel J; Janssen R; Wit JM; Romijn JA
    Eur J Endocrinol; 2007 Feb; 156(2):155-65. PubMed ID: 17287404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide suppressed interleukin-6 but not tumor necrosis factor-alpha in volunteers with experimental endotoxemia.
    Shannon E; Noveck R; Sandoval F; Kamath B; Kearney M
    Transl Res; 2007 Nov; 150(5):275-80. PubMed ID: 17964516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.